Full Length Research Paper
References
|
Arjunan M, Al-Salamah A, Amuthan M (2010). Prevalence and antibiotics susceptibility of uropathogens in patients from a rural environment, Tamilnadu. Am. J. Infect. Dis. 6(2):29. Crossref |
||||
| Assefa A, Asrat D, Woldeamanuel Y, Abdella A, Melesse T, Hiwot GY (2008). Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia. Ethiop. Med. J. 4(3):227-235. | ||||
| Bae E, Lee S, Jeong D, Kang J (2010). Clinical Characteristics and Antibiotic Resistance of Urinary Tract Infections in Children: Escherichia. coli Versus Non-E. coli. Korean J. Pediatr. Infect. Dis. 17(2):67-73. | ||||
|
Barber A, Norton J, Spivak A, Mulvey M (2013). Urinary tract infections: current and emerging management strategies. Clin. Infect. Dis. 57(5):719-724. Crossref |
||||
|
Bauer AW, Kirby WMM, Sherris JC, Turck M (1966). Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45(4):493. Pubmed |
||||
| Den Heijer C, Donker G, Maes J, Stobberingh E (2013). Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients. Prevalence and resistance of the commensal flora in non-hospitalized patients. 65: 61. | ||||
|
Epoke CO, Anyanwu GO, Opara AA (2000). The prevalence of significant bacteriuria in diabetic patients. Diabetic Int. 10:16-7. B F. Epidemiology of urinary tract infections: incidence, morbidity, and... - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2014 [cited 30 December 2014]. |
||||
|
Farooqi B, Shareeq F, Rizvi Q, Qureshi H, Ashfaq M (2000). Changing pattern of antimicrobial susceptibility of organisms causing community acquired urinary tract infections. J-Pak. Med. Assoc. 50(11):369-373. Pubmed |
||||
|
Fluit A, Schmitz F, Jones M, Acar J, Gupta R, Verhoef J (1999). Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. Int. J. Infect. Dis. 3(3):153-156. Crossref |
||||
|
Foxman B (2002). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113(1):5-13. Crossref |
||||
|
Fridkin S, Srinivasan A (2014). Implementing a Strategy for Monitoring Inpatient Antimicrobial Use Among Hospitals in the United States. Clin. Infect. Dis. 58(3):401-406. Crossref |
||||
|
Garcia Garcia MI, Munoz Bellido JL, García-Rodríguez JA (2007). In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in Spain: a comparative multicenter study (2002-2004). J. Chemother. 19(3):263-270. Crossref |
||||
|
Gonzalez C, Schaeffer A (1999). Treatment of urinary tract infection: what's old, what's new, and what works. World J. Urol. 17(6):372-382. Crossref |
||||
|
Gul N, Mujahid T, Ahmed S (2004). Isolation, identification and antibiotic resistance profile of indigenous bacterial isolates from urinary tract infection patients. Pak. J. Biol. Sci. 7(12):2051-2054. Crossref |
||||
|
Gupta K, Hooton T, Stamm W (2001). Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann. Intern. Med. 135(1):41-50. Crossref |
||||
|
Heginbothom M, Magee J, Bell J, Dunstan F, Howard A, Hillier S, Palmer S, Mason BW, Welsh Antibiotic Study Group (2004). Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance. J. Antimicrob. Chemother. 53(6):1010-1017. Crossref |
||||
|
Kahlmeter G (2003). Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO\textperiodcentered SENS study. International journal of antimicrobial agents. 22:49-52. Crossref |
||||
|
Karlowsky J, Kelly L, Thornsberry C, Jones M, Sahm D (2002). Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob. Agents Chemother. 46(8):2540-2545. Crossref |
||||
|
Karlowsky J, Lagac\'E-Wiens P, Simner P, Decorby M, Adam H, Walkty A, Hoban D, Zhanel G (2011). Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob. Agents Chemother. 55(7):3169-3175. Crossref |
||||
| Kashef N, Djavid G, Shahbazi S (2010). Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran, Iran. J. Infect. Dev. Countr. 4(04):202-206. | ||||
| Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK, Durowade KA, Kolawole CF (2009). Prevalence of urinary tract infections (UTI) among patients attending Dalhatu Araf Specialist Hospital, Lafia, Nasarawa state, Nigeria. Int. J. Med. Sci. 1(5):163-167. | ||||
| Kothari A, Sagar V (2008). Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J. Infect. Dev. Count. 2(05):354-358. | ||||
|
Linhares I, Raposo T, Rodrigues A, Almeida A (2013). Frequency and antimicrobial susceptibility patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect. Dis. 13(1):19. Crossref |
||||
|
Mazzulli T (2002). Resistance trends in urinary tract pathogens and impact on management. J. Urol. 168(4):1720-1722. Crossref |
||||
|
Novara G (2008). Editorial Comment on: Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy. Eur. Urol. 54(5):1175-1176. Crossref |
||||
| Rahman F, Chowdhury S, Rahman M, Ahmed D, Hossain A (2009). Antimicrobial susceptibility pattern of gram-negative bacteria causing urinary tract infection. Stamford J. Pharmaceut. Sci. 2(1):44-50. | ||||
| Rao D, Basu R, Sarkar A, Bidyarani K (2013). Prevalence and Antimicrobial Susceptibility Pattern of Streptococcus Pneumoniae Isolated From Respiratory Samples in a South Indian Tertiary Care Hospital. Int. J. Health Sci. Res. (IJHSR). 3(11):121-126. | ||||
| Rock W, Colodner R, Chazan B, Elias M, Raz R (2007). Ten years surveillance of antimicrobial susceptibility to community-acquired Escherichla coll and other uropathogens in Northern Israel (1995-2005). Isr. Med. Assoc. J. Ramat-Gan 9(11):803. | ||||
|
Sharif SI, OHM Ibrahim, Mouslli L, Waisi R (2012). Evaluation of self-medication among pharmacy students. Am. J. Pharmacol. Toxicol. 7:135-140. Crossref |
||||
| Sire J, Nabeth P, Perrier-Gros-Claude J, Bahsoun I, Siby T, Macondo E, Gaye-Diallo A, Guyomard S, Seck A, Breurec S, Garin B (2007). Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal. J. Infect. Dev. Count. 1(03):263-268. | ||||
|
Stamm W (2006). Theodore E. Woodward Award: host-pathogen interactions in community-acquired urinary tract infections. Transactions of the American clinical and climatological association. 117:75. Pubmed |
||||
|
Stock I, Burak S, Sherwood KJ, Gruger T, Wiedemann B (2003). Natural antimicrobial susceptibilities of strains of unusual Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea. J. Antimicrob. Chemother. 51(4):865-885. Crossref |
||||
|
Traub W (2000). Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens. Chemother. 46(5):315-321. Crossref |
||||
|
Turner P (2008). Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Diagn. Microbiol. Infect. Dis. 60(2):185-192. Crossref |
||||
| Ullah F, Malik S, Ahmed J (2009). Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. Afr. J. Biotechnol. 8:16. | ||||
|
Wiles T, Kulesus R, Mulvey M (2008). Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85(1):11-19. Crossref |
||||
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
